Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anil K. Thotakura
Observed names:
A. K. Thotakura,
A. Thotakura,
Anil K Thotakura,
Anil Kumar Thotakura,
Anil Thotakura,
Anil K. Thotakura,
Thotakura, Anil
show all 7
Observed institutions:
Babraham Institute,
Hammersmith Hospital,
Orion Corporation (Finland),
Kymab (United Kingdom),
Abcam (United Kingdom),
Imperial College London,
Orion Corporation (United Kingdom)
show all 7
OpenAlex ID:
A5108235446
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
2012
·
Laura Tornatore
, Anil K. Thotakura
, et al.
·
Trends in Cell Biology
·
461
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
2011
·
Claudio Mauro
, Shi Chi Leow
, et al.
·
Nature Cell Biology
·
405
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
2014
·
Laura Tornatore
, Annamaria Sandomenico
, et al.
·
Cancer Cell
·
109
PDF
Cancer: NF-κB regulates energy metabolism
2012
·
Marta Moretti
, Jason Bennett
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
57
An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2020
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
·
Cancer Immunology Research
·
56
PDF
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
2023
·
Anna E. Brunell
, Riitta Lahesmaa
, et al.
·
Frontiers in Immunology
·
46
PDF
Long-Range Regulatory Synergy Is Required to Allow Control of the TAC1 Locus by MEK/ERK Signalling in Sensory Neurones
2010
·
Lynne Shanley
, Scott Davidson
, et al.
·
Neurosignals
·
22
PDF
Ex vivo modeling of precision immuno-oncology responses in lung cancer
2024
·
Bassel Alsaed
, Johannes Smolander
, et al.
·
Science Advances
·
16
PDF
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
2025
·
Rita Turpin
, Karita Peltonen
, et al.
·
OncoImmunology
·
11
PDF
Establishing a GMP-compliant manufacturing process and phase-appropriate analytics for early development of a FiCAR T-cell product with a novel CAR spacer
2025
·
Annu Luostarinen
, Arja Vuorela
, et al.
·
Scientific Reports
·
9
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
2014
·
Laura Tornatore
, Annamaria Sandomenico
, et al.
·
Cancer Cell
·
8
PDF
A first-in-human study of KY1044, a fully human anti-ICOS IgG1 antibody as monotherapy and in combination with atezolizumab in patients with selected advanced malignancies.
2019
·
Sonia Quaratino
, Richard Sainson
, et al.
·
Journal of Clinical Oncology
·
7
The Regulation of the JNK Cascade and Programmed Cell Death by NF-κB: Mechanisms and Functions
2013
·
Jason Bennett
, Marta Moretti
, et al.
·
Springer eBooks
·
3
Tumor-immune crosstalk in lung cancer: emerging roles of long non-coding RNAs
2026
·
Upasna Madan
, Riitta Lahesmaa
, et al.
·
Frontiers in Immunology
·
1
PDF
Abstract 863: A novel SIRPA based FiCAR T cells therapy targeting TYRP1 to treat melanoma patients
2025
·
Henrik Paavilainen
, Sakari Pöysti
, et al.
·
Cancer Research
·
1
Abstract 2792: The combination of immune checkpoint blockers with the anti-ICOS KY1044 antibody results in a strong tumor response
2018
·
Richard C. Sainson
, Matthew McCourt
, et al.
·
Cancer Research
·
1
375 Simultaneous blocking of PVRIG and PD-L1 demonstrated enhanced immune activation and anti-tumour efficacy in pre-clinical mouse tumour models
2026
·
Anil K Thotakura
, Can Hekim
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
623 Blocking IL-20RB/IL-20 pathway enhances anti-tumour immune response in preclinical mouse tumour model
2026
·
Anil K Thotakura
, Sara Feola
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract C059: Development of a Differentiated, Best-in-Class Oral Cbl-b Inhibitor with Robust Immune Activation and Favourable Safety for Cancer Immunotherapy
2025
·
Chandregowda Venkateshappa
, Sandeep Patil
, et al.
·
Molecular Cancer Therapeutics
Stabilizing Long CARs for Optimal Anti-Tumor Responses in Hematological Malignancies
2025
·
Jan Koski
, Henrik Paavilainen
, et al.
·
Research Square
PDF
Abstract 914: Differential expression of Cbl-b in tumor infiltrating immune cells in patients with solid tumors
2025
·
Elli Narvi
, Reetta Virtakoivu
, et al.
·
Cancer Research
190P Ex vivo modeling of precision immuno-oncology responses in lung cancer
2024
·
B. Alsaed
, J. Smolander
, et al.
·
Immuno-Oncology Technology
PDF
Abstract 4223: The dual immunestimulatory and immunesuppressive role of MRC5 fibroblast cells in 3D coculture with T cells and tumor cells
2024
·
Ilona Arnkil
, Can Hekim
, et al.
·
Cancer Research
Abstract 47: Stabilization of long CAR T cells is crucial for in vivo antitumor efficacy
2024
·
Henrik Paavilainen
, Jan Koski
, et al.
·
Cancer Research
1044 High dose of rhIL-10 enhances CD8 T cell and NK cell mediated tumor cell killing in vitro
2023
·
Elli Narvi
, Anna Brunell
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
55
Citation count:
1,213
H-index:
9
I10-index:
9
Year
Topic
Type
